PharmaNet’s Neuroscience team provides equal measure of both medical and operational expertise, with professionals from both sides working together in dedicated project teams. Medical professionals include board-certified physicians and other neuroscience-experienced clinicians, with operations expertise provided by clinical research associates, project managers, data management professionals, biostatisticians, and medical writers.
The PharmaNet Neuroscience team conducts outsourced trials in psychiatry, neurology, pain management, and other CNS-related areas. The team has experience in all stages of development and has the depth and breadth of experience to conduct studies on any scale from regional to large, global programs. All services are available on a stand-alone basis or as part of larger drug development programs.
Along with its experience and expertise, the PharmaNet Neuroscience team also offers key competitive advantages:
 |
Strong relationships with many of the world’s leading medical centers and specialists, enabling access to a large network of investigators and patient populations. |
 Senior-management oversight of all projects. |
|
|
A collaborative approach among team members and sponsor staff to share best practices and knowledge about the competitive landscape. |
Case Studies
3. Migraine
5. Parkinson’s Disease, Phase II
6. Parkinson’s Disease, Phase III
Steven Leventer, PhD Vice President, Clinical Research Dr. Leventer has more than twenty years of experience in all phases of drug development. He has spent most of his career leading clinical teams at large global pharmaceutical and contract research organizations in the development of therapeutics for Alzheimer’s disease, schizophrenia, depression, and other central nervous system diseases. He was trained as a neurochemist and has had postdoctoral fellowships and faculty appointments at the University of Texas, Western Psychiatric Institute and Clinic, and Loyola University Stritch School of Medicine. |
Marc Kamin Vice President, Medical and Scientific Affairs, Neuroscience Dr. Kamin is a neurologist, certified by the American Board of Psychiatry and Neurology, with twenty years experience in the pharmaceutical industry. Most recently, Dr. Kamin was at Johnson & Johnson, where he led the Central Trial Coordination group for Medical Affairs in Global Clinical Operations. Dr. Kamin has designed and managed trials in many areas of neuroscience including migraine, eating disorders, bipolar disorder, alcohol addiction, acute and chronic pain, multiple sclerosis, epilepsy, peripheral neuropathy, amyotrophic lateral sclerosis and fibromyalgia. |
504 Carnegie Center, Princeton, NJ 08540